Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Medtech Ventures | Endovascular Cerebral Aneurysm Repair Market Current Situation & Future Outlook

Endovascular Cerebral Aneurysm Repair Market Current Situation & Future Outlook

The market for Endovascular Cerebral Aneurysm Repair (ECAR) has grown significantly since its inception in the mid-90s and the devices available for use in such procedures have evolved rapidly since the introduction of Guglielmi Detachable Coils (GDC) over a decade ago.

The introduction of biomaterial coating options to basic naked platinum wire and the introduction of stent assisted coil insertion option for the treatment of wide-necked cerebral aneurysm is expanding the market which has been growing at an average compound annual growth rate of 22% over the past five years.

The original treatment paradigm that relied on embolic coils or liquid embolics to occlude the aneurysm sac is being supplemented with the addition of stents that can be used to treat wide neck aneurysm in stent assisted coil insertion procedures or as stand alone flow diverting monotherapy devices.

Stents that are designed to reconstruct the parent vessel, slow flow within the aneurismal sac and physiologically seal the aneurysm by allowing an organized thrombus to form, have already been launched in Europe with many in advanced clinical trials stages with promising results.

This is poised to further expand the market by allowing difficult to treat cases access to the safer endovascular approach. It is also expected to reshuffle market shares among existing players on the bases of their readiness to innovate and launch next generation devices that address newly emerging treatment strategies

The market for the Endovascular Treatment of Cerebral Aneurysms, which currently stands at US$660 million globally, is expected to double over the next seven years with the newly created flow diverting stents segment providing the main engine for growth.

Medtech Ventures' Endovascular Cerebral Aneurysm Repair Market - Current Situation & Future Outlook is an exclusive introduction to this rapidly growing market. The report provides a brief, but thorough, analysis of the market with profiles of leading participants and forecasts to the year 2015.

With Endovascular Cerebral Aneurysm Repair Market - Current Situation & Future Outlook, you'll be able to better:

- Assess market size and growth potential for coils, neuro stents and access devices.

- Identify emerging technologies and the companies behind them.

- Leverage your own technology and brain storm new business opportunities.

- Understand current market dynamics, competitors' positions and market shares.

- Assess market potential and have access to forecasts till 2015.

- Monitor the competition's marketed and in-development products.

- Investigate mergers, acquisitions and licensing possibilities.

- Get a feel of the magnitude of the opportunity that fluid diverting stents presents and contemplate your company position towards this market transforming technology.

Endovascular Cerebral Aneurysm Repair Market - Current Situation & Future Outlook is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this transforming growth area.

Report Code: MV080701

Publisher: Medtech Ventures

Date Published: July 2008

Number of Pages: 30

Report Price:

PDF file by email: $2,950

Site License: $5,900

Table of Contents

Price

PDF Single User $2950.00

PDF Site Licence $5900.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions